Abstract
Almost 1 in 10 patients with non-rheumatic atrial fibrillation is at risk of stroke. This article describes the risk factors and assesses the role of aspirin and warfarin in stroke prevention.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Aged
-
Atrial Fibrillation / complications*
-
Cerebrovascular Disorders / prevention & control*
-
Female
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Risk Factors
-
Thrombolytic Therapy